title: Design, synthesis, and validation of a β-turn mimetic library targeting protein-protein and peptide-receptor interactions.
abstract: The design and synthesis of a β-turn mimetic library as a key component of a small-molecule library targeting the major recognition motifs involved in protein-protein interactions is described. Analysis of a geometric characterization of 10,245 β-turns in the protein data bank (PDB) suggested that trans-pyrrolidine-3,4-dicarboxamide could serve as an effective and synthetically accessible library template. This was confirmed by initially screening select compounds against a series of peptide-activated GPCRs that recognize a β-turn structure in their endogenous ligands. This validation study was highlighted by identification of both nonbasic and basic small molecules with high affinities (K(i) = 390 and 23 nM, respectively) for the κ-opioid receptor (KOR). Consistent with the screening capabilities of collaborators and following the design validation, the complete library was assembled as 210 mixtures of 20 compounds, providing a total of 4200 compounds designed to mimic all possible permutations of 3 of the 4 residues in a naturally occurring β-turn. Unique to the design and because of the C(2) symmetry of the template, a typical 20 × 20 × 20-mix (8000 compounds prepared as 400 mixtures of 20 compounds) needed to represent 20 variations in the side chains of three amino acid residues reduces to a 210 × 20-mix, thereby simplifying the library synthesis and subsequent screening. The library was prepared using a solution-phase synthetic protocol with liquid-liquid or liquid-solid extractions for purification and conducted on a scale that insures its long-term availability for screening campaigns. Screening the library against the human opioid receptors (KOR, MOR, and DOR) identified not only the activity of library members expected to mimic the opioid receptor peptide ligands but also additional side-chain combinations that provided enhanced receptor binding selectivities (>100-fold) and affinities (as low as K(i) = 80 nM for KOR). A key insight to emerge from the studies is that the phenol of Tyr in endogenous ligands bearing the H-Tyr-Pro-Trp/Phe-Phe-NH(2) β-turn is important for MOR binding but may not be important for KOR (accommodated, but not preferred) and that the resulting selectivity for KOR observed with its removal can be increased by replacing the phenol OH with a chlorine substituent, further enhancing KOR affinity.
authors: Department of Chemistry and The Skaggs Institute for Chemical Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, USA.
authors: Landon R
authors: LR
authors: Whitby
authors: Yoshio
authors: Y
authors: Ando
authors: Vincent
authors: V
authors: Setola
authors: Peter K
authors: PK
authors: Vogt
authors: Bryan L
authors: BL
authors: Roth
authors: Dale L
authors: DL
authors: Boger
references: Org Lett. 2005 Feb 3;7(3):399-402
references: 15673249
references: J Am Chem Soc. 2001 Feb 21;123(7):1280-8
references: 11456699
references: Chem Rev. 1997 Aug 5;97(5):1233-1250
references: 11851449
references: Chem Biol Drug Des. 2007 Feb;69(2):99-110
references: 17381723
references: J Med Chem. 2010 Jul 8;53(13):5044-8
references: 20540510
references: Angew Chem Int Ed Engl. 2009;48(26):4725-9
references: 19266506
references: Bioorg Med Chem. 1998 Aug;6(8):1347-78
references: 9784874
references: Bioorg Med Chem. 2010 Nov 1;18(21):7611-20
references: 20869252
references: J Biol Chem. 2008 Jul 4;283(27):18734-42
references: 18474596
references: Curr Top Med Chem. 2007;7(1):33-62
references: 17266595
references: Chem Rev. 2005 Mar;105(3):793-826
references: 15755077
references: ACS Med Chem Lett. 2010 Aug 12;1(5):189-193
references: 20729985
references: Org Biomol Chem. 2010 May 21;8(10):2344-51
references: 20448891
references: Oncol Rep. 2008 Mar;19(3):825-30
references: 18288422
references: Org Lett. 2006 Mar 16;8(6):1177-9
references: 16524297
references: Bioorg Med Chem. 2003 Nov 17;11(23):5059-68
references: 14604669
references: Nature. 2007 Dec 13;450(7172):1001-9
references: 18075579
references: Brain Res. 2010 Feb 16;1314:44-55
references: 19716811
references: Bioorg Med Chem Lett. 2009 Jul 15;19(14):3771-4
references: 19428249
references: J Am Chem Soc. 2002 May 15;124(19):5431-40
references: 11996584
references: Pharmacol Rev. 2007 Mar;59(1):88-123
references: 17329549
references: Nat Rev Drug Discov. 2004 Apr;3(4):301-17
references: 15060526
references: Curr Opin Chem Biol. 2009 Jun;13(3):284-90
references: 19553156
references: Bioorg Med Chem. 1996 May;4(5):727-37
references: 8804539
references: J Org Chem. 2001 Oct 5;66(20):6654-61
references: 11578217
references: J Org Chem. 2008 May 2;73(9):3608-11
references: 18363364
references: ChemMedChem. 2010 Aug 2;5(8):1176-96
references: 20491136
references: J Med Chem. 2002 Apr 11;45(8):1543-58
references: 11931608
references: Mini Rev Med Chem. 2002 Oct;2(5):447-62
references: 12370046
references: J Org Chem. 2009 Nov 6;74(21):8098-105
references: 19785471
references: Bioorg Med Chem Lett. 2009 Jul 15;19(14):3779-82
references: 19435662
references: Bioorg Med Chem Lett. 2006 Mar 15;16(6):1740-3
references: 16427279
references: J Comb Chem. 2007 Jul-Aug;9(4):704-10
references: 17429950
references: J Org Chem. 2009 Jun 5;74(11):4429-32
references: 19438186
references: J Med Chem. 2011 Mar 10;54(5):1462-72
references: 21287991
references: J Org Chem. 2009 Mar 6;74(5):2189-92
references: 19191573
references: J Am Chem Soc. 2002 Jan 30;124(4):544-55
references: 11804483
references: AAPS J. 2006 Mar 10;8(1):E126-37
references: 16584119
references: Acc Chem Res. 2001 Oct;34(10):826-35
references: 11601967
references: Angew Chem Int Ed Engl. 2005 Jul 4;44(27):4130-63
references: 15954154
references: Curr Med Chem. 2007;14(30):3201-8
references: 18220754
references: Chem Biol. 2002 Nov;9(11):1219-26
references: 12445772
references: Acc Chem Res. 2009 Oct 20;42(10):1511-20
references: 19624154
references: ACS Chem Biol. 2009 Sep 18;4(9):769-81
references: 19735123
references: Acc Chem Res. 2011 Mar 15;44(3):180-93
references: 21175156
references: ChemMedChem. 2009 Apr;4(4):517-23
references: 19226499
references: J Am Chem Soc. 2011 Jan 26;133(3):462-77
references: 21182254
references: Eur J Med Chem. 2005 Jul;40(7):674-86
references: 15935902
references: Curr Top Med Chem. 2004;4(1):105-21
references: 14754379
references: J Am Chem Soc. 2008 Jan 16;130(2):556-65
references: 18088119
references: J Comput Aided Mol Des. 1999 Sep;13(5):485-98
references: 10483530
references: Angew Chem Int Ed Engl. 2003 Feb 3;42(5):535-9
references: 12569483
references: Chem Soc Rev. 2009 Dec;38(12):3289-300
references: 20449049
references: Bioorg Med Chem Lett. 2005 Jan 17;15(2):287-90
references: 15603941
references: J Am Chem Soc. 2001 Jun 27;123(25):5878-91
references: 11414820
references: J Am Chem Soc. 2009 Mar 11;131(9):3342-8
references: 19216569
references: Biopolymers. 2003 Apr;68(4):497-511
references: 12666175
references: Chem Rev. 2010 Jun 9;110(6):PR32-69
references: 20384343
references: AAPS J. 2009 Jun;11(2):312-22
references: 19430912
references: Bioorg Med Chem Lett. 2009 Nov 1;19(21):6038-41
references: 19800226
references: Curr Pharm Des. 2003;9(15):1209-24
references: 12769748
references: J Med Chem. 2002 Mar 28;45(7):1395-8
references: 11906279
references: J Am Chem Soc. 2009 Apr 22;131(15):5564-72
references: 19334711
references: Proc Natl Acad Sci U S A. 2007 Feb 20;104(8):2602-7
references: 17293454
references: Nature. 1997 Apr 3;386(6624):499-502
references: 9087409
references: Peptides. 2010 Nov;31(11):2135-40
references: 20713109
references: ACS Comb Sci. 2011 Mar 14;13(2):107-11
references: 21395339
references: Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3830-5
references: 11891322
references: Biopolymers. 2006;84(6):535-52
references: 17009316
references: Curr Opin Drug Discov Devel. 2008 Sep;11(5):666-74
references: 18729018
references: J Med Chem. 2002 Dec 19;45(26):5617-9
references: 12477343
references: J Comput Aided Mol Des. 1999 Sep;13(5):469-83
references: 10483529
references: Curr Protein Pept Sci. 2008 Jun;9(3):240-7
references: 18537679
references: J Comput Aided Mol Des. 2006 Feb;20(2):109-30
references: 16622794
references: Bioorg Med Chem Lett. 1998 Sep 8;8(17):2339-44
references: 9873538
references: Proteins. 2007 Sep 1;68(4):803-12
references: 17546660
references: Proc Natl Acad Sci U S A. 2001 Jan 2;98(1):119-24
references: 11134507
references: Brain Res Rev. 2009 Dec 11;62(1):127-46
references: 19804796
references: J Comb Chem. 2006 May-Jun;8(3):315-25
references: 16677000
references: Org Lett. 2011 Mar 4;13(5):980-3
references: 21268601
references: Biochem J. 2010 Aug 1;429(3):527-32
references: 20507280
references: Bioorg Med Chem. 2003 Apr 17;11(8):1607-13
references: 12659745
references: Bioorg Chem. 2009 Jun;37(3):90-5
references: 19467690
references: Bioorg Med Chem Lett. 2005 Jun 2;15(11):2840-4
references: 15911265
references: J Org Chem. 2000 Mar 10;65(5):1467-74
references: 10814111
references: Philos Trans A Math Phys Eng Sci. 2010 Mar 13;368(1914):989-1008
references: 20123744
references: Angew Chem Int Ed Engl. 2003 Sep 15;42(35):4138-76
references: 14502729
references: Chem Commun (Camb). 2009 Sep 14;(34):5091-3
references: 20448956
references: Acta Pharmacol Sin. 2010 Sep;31(9):1065-70
references: 20729876
references: Curr Top Med Chem. 2007;7(10):928-42
references: 17508924
references: Acc Chem Res. 2004 Jan;37(1):61-9
references: 14730995
references: Chem Rev. 2007 Jul;107(7):2960-3041
references: 17622179
references: Med Res Rev. 2004 Mar;24(2):182-212
references: 14705168
references: J Pept Res. 2003 Oct;62(4):145-57
references: 12969194
references: Org Biomol Chem. 2008 Jan 7;6(1):138-46
references: 18075658
references: Chem Rev. 2010 Apr 14;110(4):PR1-41
references: 20196554
references: Bioorg Med Chem. 2001 Mar;9(3):557-62
references: 11310589
references: Chem Rev. 2000 Jul 12;100(7):2479-94
references: 11749292
references: J Med Chem. 2008 Jan 10;51(1):173-7
references: 18062664